Trial intelligence / Profile preview

Effects of dexmedetomidine on cardiac electrophysiology in adults

2010-020782-24Phase 4Completed

Sponsor
Helsinki University Hospital
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of dexmedetomidine in Atrial fibrillation (AFib), sponsored by Helsinki University Hospital. Primary endpoint: Change in electrophysiological measurements before and after dexmedetomidine. Started Oct 2010; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on 2010-020782-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020782-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call